Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Naoto Tada Ueno
Observed names:
Naoto T. Ueno,
Ueno, Naoto T.
Institutions:
University of Hawaiʻi at Mānoa,
The University of Texas MD Anderson Cancer Center,
University of Hawaii Cancer Center
Observed institutions:
University of Hawaiʻi at Mānoa,
The University of Texas MD Anderson Cancer Center,
University of Hawaii Cancer Center
ORCID:
0000-0002-0166-7275
Observed ORCID:
0000-0002-0166-7275
OpenAlex ID:
A5146719371
Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
2026
·
Dileep Reddy Rampa
, Minji Seo
, et al.
·
Clinical Cancer Research
·
32
PDF
Predictive value of the Cancer and Aging Research Group Score for chemotherapy toxicities in older adults with cancer: a systematic review and meta-analysis
2026
·
Kohei Horiuchi
, Toshiki Kuno
, et al.
·
Supportive Care in Cancer
·
5
CD44v9 as a therapeutic target for antibody-drug conjugate in advanced breast cancer
2026
·
Dileep R. Reddy
, McKenna E. Flynn
, et al.
·
Biomedicine & Pharmacotherapy
·
2
High levels of circulating miR-19a-3p in patients with metastatic HER2 + breast cancer are associated with a favorable prognosis and anti-tumor immune responses
2026
·
Evan N. Cohen
, Hui Gao
, et al.
·
Breast Cancer Research
·
2
PDF
Measuring KEYNOTE-522 response from TNBC patient biopsies ex vivo using the E-slice assay.
2026
·
Kyuson Yun
, Viridiana Leyva-Aranda
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Abstract A013: Preclinical Development of a Humanized CD44v9-Directed Antibody-Drug Conjugate for Treatment-Refractory Breast Cancer
2026
·
Naoto T. Ueno
, Dileep R. Reddy
, et al.
·
Clinical Cancer Research
Less Can Be More by Circulating Tumor DNA Use in ERBB2 -Positive Breast Cancer
2026
·
Naoto T. Ueno
·
JAMA Oncology
Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial
2026
·
Kamaria L. Lee
, Clinton Yam
, et al.
·
Breast Cancer Research and Treatment
PDF
ZIP-code–level distress as a predictor for advanced stage and mortality in female breast cancer across a multiethnic cohort in Hawaiʻi.
2026
·
Chalothorn Wannaphut
, Jodi A. Kagihara
, et al.
·
Journal of Clinical Oncology
PDF
Reprogramming the Immune Landscape of Inflammatory Breast Cancer
2026
·
Verena Martinez‐Rodriguez
, Suguru Ogata
, et al.
·
Advanced Science
High levels of circulating miR-19a-3p in patients with metastatic HER2 + breast cancer are associated with a favorable prognosis and anti-tumor immune responses
2026
·
Cohen, Evan N.
, Gao, Hui
, et al.
·
Figshare
Show more works
View as search
Works count:
13
Citation count:
42
H-index:
2
I10-index:
1
Year
Topic
Type